Sponsor:
University Health Network, Toronto
Code:
NCT04962672
Conditions
Anesthesia
Brain Cancer
Survival
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Propofol group
Sevoflurane group
Brief summary:
Conditions
Anesthesia
Brain Cancer
Survival
Study ID
NCT04962672
Start date
Jan 1, 2022
Status verified date
Jan, 2025
Completion date
Sep 30, 2025
Anticipated
Primary completion date
Jul 1, 2025
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
40 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Supportive Care
Arms
experimental: Propofol group
active comparator: Sevoflurane group
Interventions
Propofol group
Sevoflurane group
Primary outcome measure
Central contacts
Locations
Toronto Western Hospital/UHN
Recruiting
Toronto, Ontario, Canada, M5T 2S8
Contacts
Sponsor
University Health Network, Toronto
Last update posted
Jan 31, 2025
Last verified
Jan, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University Health Network, Toronto on 2025-01-31.